News & Articles
Selected Filters:
SpeeDx and Thermo Fisher Scientific Announce Strategic Partnership for FDA Clearance of Molecular Diagnostic Test
The new test would bring disease and antibiotic resistance testing for potential “superbug”
New Research Suggests Potential for Additional Clinical Utility of QIAGEN’s Quantiferon-TB Gold Plus
Findings indicate increased specificity in low-risk populations and potential for monitoring tuberculosis treatment
ADVIA Centaur XPT by Siemens Healthineers Offers Laboratories a Comprehensive Menu for Infectious Disease Testing
Automated repeat and confirmatory testing of reactive samples through SMART algorithm software and Hot Zone capabilities reduce the need for additional testing
Webinar Highlights – Real-Time Live-Cell Analysis for Immunologists
Dr. Del Trezise answers your questions about using real-time cell imaging to gain deeper insights into immune cells
University Hospital Basel Institute of Pathology Established as Thermo Fisher Scientific Center of Excellence Partner
Agreement centered on next-generation sequencing oncology research and companion diagnostic development programs
How to Overcome Reproducibility Issues in Flow Cytometry
Discover why recombinantly engineered REAfinity Antibodies offer improved consistency, reproducibility and purity over traditionally produced monoclonal antibodies
Acoustic Dispensing for High Throughput Single Cell Sequencing Workflows
Improving RNA single cell genomics and sequencing library preparation protocols
Singulex Announces CE Mark for Sgx Clarity® System
European CE mark enables commercialization of IVD platform powered by Single Molecule Counting technology
Standardisation of Cancer Biomarker Detection
Husband & Wife Duo Combating Dementia Through Neurological Research
Meet the couple combining stroke research & Alzheimer’s expertise in the hope of understanding mixed dementia
QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows
Public-private partnership aims to standardize and clinically validate blood-based biomarkers
New FDA-Cleared JAK2 Biomarker Test for Blood Cancer Type
New biomarker test designed to aid diagnosis of patients suspected of having Polycythemia Vera form of blood cancer
Miltenyi Biotec Supports AACR Symposium, Poster Session and Runners for Research 5k Run/Walk
Booth #2607























